Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
Enbridge Inc
ENB
4
Air Canada
AC
5
BCE Inc
BCE
CA Stock MarketDetailed Quotes
METX ME Therapeutics Holding Inc
- 7.500
- 0.0000.00%
15min DelayTrading Feb 26 14:19 ET
221.92MMarket Cap-150.00P/E (TTM)
0.000High0.000Low0Volume0.000Open7.500Pre Close0.00Turnover8.05052wk High0.00%Turnover Ratio29.59MShares0.75052wk Low-0.05EPS TTM70.12MFloat Cap8.050Historical HighLossP/E (Static)9.35MShs Float0.050Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM166.67P/B1Lot Size--Div YieldTTM
About ME Therapeutics Holding Inc Company
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.
Company Profile
SymbolMETX
Company NameME Therapeutics Holding Inc
Founded2021
MarketCNQ
Employees1
Fiscal Year Ends08-31
Address 177 Robson St.
CityVancouver
CountryCAN
Zip CodeV6B 0N3
Phone+1 236 516-7714
Company Executives
- Name
- Position
- Salary
- Salim Zulifkar Dhanji
- Director and Chief Executive Officer
- --
- Quinn Martin
- Chief Financial Officer
- --
- Kenneth Harder
- Independent Director
- --
- Karim Nanji
- Independent Director
- --
- John Priatel
- Independent Director
- --
- Jamil Kassam
- Corporate Secretary
- --